Immunofluorescence studies using the KM55 antibody have demonstrated glomerular deposition of Gd-IgA1, offering new insights into the potential role of Gd-IgA1 as a crucial effector molecule in IgA nephropathy [14, 15]. This evidence concerns the gene IGHA1 and IgA glomerulonephritis.